My Top 4 Favorite Stocks right now! 👀
$NuCana(NCNA.US)$ $Lockheed Martin(LMT.US)$ $Tesla(TSLA.US)$ $AMC Entertainment(AMC.US)$
@Investing with moomoo @In One Chart @Moomoo Event @Moomoo US @Moomoo Learn @Moomoo Recap US @Moomoo Breakfast US @Moomoo IPO Buzz @Moomoo News US @Moo Live @moomoo Rewards @Popular on moomoo @Team moomoo

New updated Analyst Rating for $NuCana(NCNA.US)$ RAISED the LOW PRICE TARGET from $4.77 TO $244.20 ?!? 🤯👀
See New and Old Analyst Ratings below… Very interesting for a Stock under $1.00 🤔
$AMC Entertainment(AMC.US)$ $GameStop(GME.US)$ $Tesla(TSLA.US)$
@In One Chart @Moo Live @Popular on moomoo @Team moomoo

$NuCana(NCNA.US)$ Under $1.00 a share right now… Guess people don’t get understand that:
A.) NuCana’s market cap is not reflecting the potential of two other drug candidates NUC-3373 and NUC-7738, currently in Phase 2 trials.
B.) Cash runway until 2025 and almost 900 patents granted.
$GameStop(GME.US)$ $AMC Entertainment(AMC.US)$ $Tesla(TSLA.US)$
@In One Chart @Moo Live @Popular on moomoo @Team moomoo

Check out $NuCana(NCNA.US)$ Under $2.00 a share right now!
Some things to consider:
- NuCana’s market cap is not reflecting the potential of two other drug candidates NUC-3373 and NUC-7738, currently in Phase 2 trials.
- The UK and EU proceedings against Gilead for alleged years-long infringement of an EU patent have important hearing dates lined up in January and March 2023.
- Total overdue license fees / damages could be about $920 million, and infringement is ongoing...

Check out $NuCana(NCNA.US)$ ! Under $1.50 a share right now!
Some things to consider:
- NuCana’s market cap is not reflecting the potential of two other drug candidates NUC-3373 and NUC-7738, currently in Phase 2 trials.
- The UK and EU proceedings against Gilead for alleged years-long infringement of an EU patent have important hearing dates lined up in January and March 2023.
-  Total overdue license fees / damages could be about $920 million, and infringement is ongoing at $45...

Check out $NuCana(NCNA.US)$ ! Under $1.50 a share right now!
Some things to consider:
- NuCana’s market cap is not reflecting the potential of two other drug candidates NUC-3373 and NUC-7738, currently in Phase 2 trials.
- The UK and EU proceedings against Gilead for alleged years-long infringement of an EU patent have important hearing dates lined up in January and March 2023. Total overdue license fees / damages could be about $920 million, and infringement is ongoing at $450 ...

It’s a REALLY Good Chance   $NuCana(NCNA.US)$  will win this. Billions in back pay for stealing patients. That’s why price target is so high. This won’t be Long. 🚀🌙📈🤑
$AMC Entertainment(AMC.US)$ $GameStop(GME.US)$ $Tesla(TSLA.US)$

$NuCana(NCNA.US)$  About to be owed BILLIONS of dollars worth of back pay due to   $Gilead Sciences(GILD.US)$  Patent Infringement 👀📈🤑
$Tesla(TSLA.US)$ $AMC Entertainment(AMC.US)$

BUY, BUY, BUY & HODL!! 📈🤑
My Favorite Stocks right now!
$NuCana(NCNA.US)$ $Lockheed Martin(LMT.US)$ $Tesla(TSLA.US)$ $AMC Entertainment(AMC.US)$